Von Willebrand Factor-Specific Antibodies Developing upon Treatment of FVIII-Deficient Mice with Different FVIII Preparations

By  

Acta Haematologica, Vol. 119, Iss. 4, 2008-07 ,pp. : 244-247

Karger

Access to resources Recommend Favorite

Switching from current factor VIII (FVIII) to longer acting FVIII concentrates – what is the real potential benefit?

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 297-299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allergic reaction in a cohort of haemophilia A patients using plasma‐derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII

By  

HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. : e281-e285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Die Flourishing Scale (FS) von Diener et al. liegt jetzt in einer autorisierten deutschen Fassung (FS-D) vor: Einsatz bei einer Mind-Body-medizinischen Fragestellung

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 20, Iss. 4, 2013-08 ,pp. : 267-275

Karger

Access to resources Recommend Favorite

Recombinant full‐length factor VIII (FVIII) and extended half‐life FVIII products in prophylaxis – new insight provided by pharmacokinetic modelling

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 300-306

John Wiley & Sons Inc

Access to resources Recommend Favorite